1-832-868-1888
order@swbio.com
Catalog Number: |
26013 |
other_names: | PUMA (10D4G7), p53 upregulated modulator of apoptosis, bbc3, Bcl-2 binding component 3 |
Amount: |
100μg |
calculated_mw: | |
host_species: | Mouse |
Price: |
$529 |
Swiss-Prot No: |
Q9BXH1 |
Form of Antibody: |
Supplied in PBS containing 0.02% sodium azide. |
Storage/Stability: |
|
Immunogen: |
Recombinant protein corresponding to amino acids 76 - 170 of human PUMA-alpha. |
Purification: |
Immunoaffinity chromotography purified IgG |
Specificity/Sensitivity: |
|
Applications: |
ELISA WB |
Background: |
Apoptosis is related to many diseases and development. The p53 tumor-suppressor protein induces apoptosis through transcriptional activation of several genes. A novel p53 inducible pro-apoptotic gene was identified recently and designated PUMA (for p53 upregulated modulator of apoptosis) and bbc3 (for Bcl-2 binding component 3) in human and mouse. PUMA/bbc3 is one of the pro-apoptotic Bcl-2 family members including Bax and Noxa, which are also transcriptional targets of p53. The PUMA gene encodes two BH3 domain-containing proteins termed PUMAα and PUMAβ. PUMA proteins bind Bcl-2, localize to the mitochondria, and induce cytochrome c release and apoptosis in response to p53. PUMA may be a direct mediator of p53-induced apoptosis. |
References: |
|
appl_detail: |
|
QUICK LINKS
Unique Antibodies Cancer/Apoptosis antibody Tag Antibody Neuroscience antibody MAP kinase antibody Secondary AntibodyCONTACT US
1-832-868-1888 order@swbio.comGET IN TOUCH